Integra LifeSciences Holdings logo
Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
13.44
+0.03 (0.22%)
Oct 9, 2026, 4:00 PM EDT - Market closed

IART Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, IART stock has a consensus rating of "Hold" and an average price target of $18.38. The average 1-year stock price forecast is 36.76% higher than the current stock price, while the lowest is $14 (+4.17%) and the highest is $27 (+100.89%).

Price Target: $18.38 (+36.76%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$14$18.38$16$27
Change+4.17%+36.76%+19.05%+100.89%

Analyst Ratings

The average analyst rating for IART stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy122222
Buy111111
Hold657776
Sell222222
Strong Sell000000
Total101012121211

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Citi
Citi
Hold
Maintains
$19 → $15
HoldMaintains$19 → $15+11.61%Oct 5, 2026
Truist Financial
Truist Financial
Hold
Maintains
n/a
HoldMaintainsn/an/aOct 5, 2026
BTIG
BTIG
Hold
Maintains
n/a
HoldMaintainsn/an/aOct 3, 2026
Wells Fargo
Wells Fargo
Hold
Maintains
$18 → $15
HoldMaintains$18 → $15+11.61%Oct 3, 2026
BMO Capital
BMO Capital
Hold
Maintains
$18 → $15
HoldMaintains$18 → $15+11.61%Oct 2, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.66B
from 1.64B
Increased by 1.66%
Revenue Next Year
1.72B
from 1.66B
Increased by 3.37%
EPS This Year
2.40
from 2.23
Increased by 7.62%
EPS Next Year
2.59
from 2.40
Increased by 7.88%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.54B1.56B1.54B1.61B1.64B1.66B
Revenue Growth
12.43%0.99%-1.03%4.47%1.54%1.66%
Gross Profit
944.64M970.31M884.74M959.12M919.42M1.04B
Gross Margin
61.24%62.29%57.39%59.55%56.23%62.53%
Operating Income
199.98M238.92M111.53M181.98M145.92M291.92M
Net Income
169.08M180.55M67.74M-6.94M-516.47M49.25M
EPS
----2.232.40
EPS Growth
-----12.89%7.62%
Forward PE
20.1916.1612.948.835.215.60
Free Cash Flow
-----31.05M111.90M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High1.7B
Avg1.7B
Low1.6B

Revenue Growth

Revenue Growth202620272028
High
2.4%
Avg
1.7%
Low
0.6%

EPS Forecast

EPS202620272028
High2.45
Avg2.40
Low2.34

EPS Growth

EPS Growth202620272028
High
9.9%
Avg
7.6%
Low
5.1%